GO:0006287 base-excision repair, gap-filling: Mechanism, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0006287 (base-excision repair, gap-filling) is the biological process in which the damaged DNA strand is repaired by the combined action of an AP endonuclease that removes a few bases and a DNA polymerase that synthesizes a short patch in the 5' to 3' direction using the undamaged strand as template.
DNA polymerase beta (POLB) is the primary gap-filling enzyme in mammalian base excision repair (BER), but other polymerases can substitute under certain conditions.
Gap-filling is a critical step in BER, ensuring that the single-nucleotide or short-patch repair is completed before DNA ligation seals the nick.
Defects in gap-filling can lead to accumulation of DNA breaks, genomic instability, and are associated with cancer and neurodegenerative diseases.
Active DNA demethylation involves BER gap-filling to replace oxidized methylcytosine derivatives, linking this process to epigenetic regulation and cell fate specification.
Experimental models for studying gap-filling include knockout cell lines, point mutants of POLB, and biochemical reconstitution assays using purified proteins [1,7,8].

Description

Base-excision repair (BER) is a major DNA repair pathway that removes small, non-helix-distorting base lesions caused by oxidation, alkylation, deamination, or hydrolysis. Within BER, the gap-filling step (GO:0006287) is essential for restoring the integrity of the DNA strand after the damaged base has been excised. This process involves the coordinated action of an apurinic/apyrimidinic (AP) endonuclease, which incises the DNA backbone and removes a few nucleotides, and a DNA polymerase that fills the resulting gap by synthesizing a complementary patch using the undamaged strand as a template. The gap-filling step is highly conserved from bacteria to humans and is critical for maintaining genomic stability. In mammalian cells, DNA polymerase beta (POLB) is the main enzyme responsible for gap-filling during single-nucleotide BER, but other polymerases such as POLG, POLK, and POLN can also participate under certain contexts. The choice of polymerase and the size of the repair patch (short-patch vs. long-patch) depend on the type of lesion and cellular conditions. Defects in gap-filling can result in persistent DNA breaks, mutagenesis, and cell death, highlighting its importance in cancer, aging, and neurological disorders. Recent studies have expanded the role of BER gap-filling beyond canonical DNA repair. For example, active DNA demethylation requires BER gap-filling to replace 5-methylcytosine derivatives, thereby influencing gene expression and cell fate decisions. Additionally, viral and bacterial systems have provided insights into the evolutionary conservation of this process. Understanding the molecular mechanisms of gap-filling is therefore crucial for developing therapeutic strategies that target DNA repair in diseases such as cancer.

base-excision repair, gap-filling At A Glance

GO ID GO:0006287
GO term base-excision repair, gap-filling
Ontology biological_process
Synonym none
Major function Fills the gap left after excision of a damaged base by a DNA polymerase using the undamaged strand as template
Parent term base-excision repair (GO:0006284)
Related enzymes AP endonuclease (APEX1), DNA polymerase beta (POLB), DNA ligase III (LIG3)
Pathway context Short-patch and long-patch base excision repair
Conservation Highly conserved from bacteria to humans

What Is GO:0006287?

GO:0006287, base-excision repair, gap-filling, is defined as the repair of the damaged DNA strand by the combined action of an apurinic endonuclease that degrades a few bases on the damaged strand and a polymerase that synthesizes a 'patch' in the 5' to 3' direction, using the undamaged strand as a template. This process is a sub-step of base-excision repair and ensures that the DNA strand is restored after removal of a damaged base.

Why Is base-excision repair, gap-filling Important in Cell Biology?

Gap-filling is a critical step in base-excision repair because it restores the correct DNA sequence after removal of a damaged base. Without efficient gap-filling, single-strand breaks persist, leading to replication fork collapse, double-strand breaks, and genomic instability. This process is essential for maintaining cellular homeostasis and preventing mutations that can drive cancer and other diseases. Moreover, gap-filling is involved in active DNA demethylation, linking DNA repair to epigenetic regulation and cell fate specification. Therefore, understanding the mechanisms and regulation of gap-filling has broad implications for cancer biology, neurobiology, and aging research.
Maintains genomic stability by completing base-excision repair after damaged base removal.
Prevents accumulation of cytotoxic and mutagenic single-strand breaks.
Plays a role in active DNA demethylation and epigenetic reprogramming.
Defects in gap-filling are associated with cancer predisposition and neurodegeneration.
DNA polymerase beta (POLB) is a key gap-filling enzyme and a potential drug target in cancer therapy.
Gap-filling mechanisms are conserved across species, facilitating model organism studies.
Biochemical reconstitution assays allow detailed mechanistic studies of gap-filling.
Environmental toxicants can compromise gap-filling and ligation steps, leading to repair failure.

What Happens During base-excision repair, gap-filling?

Excision of the damaged base and AP site formation
In simple terms: First, the damaged base is removed, leaving an empty spot called an AP site.
Base-excision repair is initiated by a DNA glycosylase that recognizes and removes a damaged base, creating an apurinic/apyrimidinic (AP) site. This step is lesion-specific and involves glycosylases such as OGG1 for oxidized guanine or UNG for uracil. The resulting AP site is a substrate for the next step.
AP endonuclease incision and gap generation
In simple terms: An enzyme cuts the DNA backbone at the AP site and removes a few bases, creating a gap.
AP endonuclease (APEX1 in humans) incises the DNA backbone 5' to the AP site, generating a 3'-hydroxyl and a 5'-deoxyribose phosphate (dRP) terminus. In short-patch BER, the dRP group is removed by the lyase activity of DNA polymerase beta, leaving a single-nucleotide gap. In long-patch BER, additional nucleotides are displaced, creating a longer gap.
Gap-filling by DNA polymerase
In simple terms: A DNA polymerase fills the gap by adding the correct nucleotides using the undamaged strand as a guide.
DNA polymerase beta (POLB) is the primary gap-filling enzyme in mammalian short-patch BER. It adds the missing nucleotide(s) in the 5' to 3' direction, using the complementary strand as a template. POLB also possesses dRP lyase activity, removing the 5'-dRP group. In long-patch BER, replicative polymerases such as POL delta/epsilon or POL beta may perform strand displacement synthesis. Other polymerases like POL lambda, POL iota, and POL kappa can also participate in gap-filling under specific conditions.
DNA ligation and completion of repair
In simple terms: Finally, an enzyme seals the nick to restore the continuous DNA strand.
After gap-filling, the remaining nick is sealed by DNA ligase III (LIG3) in complex with XRCC1 for short-patch BER, or by DNA ligase I (LIG1) for long-patch BER. This step completes the repair process, restoring the original DNA sequence. Defects in ligation can lead to persistent breaks and genomic instability.
Coordination and channeling in BER
In simple terms: The enzymes work together in a coordinated way to avoid releasing dangerous intermediates.
Biochemical studies have shown that BER proteins can channel substrates, meaning that the product of one step is directly passed to the next enzyme without diffusing away. This channeling is particularly important for gap-filling and ligation, as it prevents the accumulation of toxic intermediates like single-strand breaks. POLB and LIG3 interact physically, facilitating efficient repair.

Key Genes Involved in GO:0006287 base-excision repair, gap-filling

The following genes and proteins are key players in base-excision repair gap-filling, as supported by published literature.
GeneMajor RoleResearch Relevance
POLBDNA polymerase beta; main gap-filling enzyme in short-patch BERKnockout causes sensitivity to alkylating agents; point mutants affect catalytic activity
APEX1AP endonuclease; incises AP sites and generates gapKnockout is embryonic lethal; regulates BER initiation
LIG3DNA ligase III; seals nick after gap-filling in short-patch BERDefects lead to accumulation of breaks; interacts with XRCC1
XRCC1Scaffold protein; coordinates BER enzymes including POLB and LIG3Mutations associated with cancer and neurological disorders
OGG1DNA glycosylase; removes oxidized guanineDeficiency linked to cancer and aging
UNGUracil-DNA glycosylase; removes uracil from DNAKnockout affects antibody diversity and DNA repair
MUTYHDNA glycosylase; removes adenine opposite oxidized guanineMutations cause MUTYH-associated polyposis
NEIL1DNA glycosylase; removes oxidized pyrimidinesDeficiency leads to metabolic syndrome and cancer
PARP1Poly(ADP-ribose) polymerase; involved in BER regulationInhibitors used in cancer therapy; synthetic lethality with BRCA mutations
FEN1Flap endonuclease; involved in long-patch BERDeficiency causes genomic instability
PCNAProliferating cell nuclear antigen; processivity factor for long-patch BERRequired for POL delta/epsilon-mediated gap-filling
POLGMitochondrial DNA polymerase; gap-filling in mitochondrial BERMutations cause mitochondrial diseases
POLKDNA polymerase kappa; can perform gap-filling in specific contextsInvolved in lesion bypass and BER backup
POLNDNA polymerase nu; gap-filling in alternative BERMay contribute to repair in specific tissues
POLIDNA polymerase iota; gap-filling in alternative BERPotential backup polymerase
POLKDNA polymerase kappa; gap-filling in alternative BERPotential backup polymerase
LIG1DNA ligase I; seals nick in long-patch BERDeficiency causes immune deficiency and growth retardation
TDP1Tyrosyl-DNA phosphodiesterase 1; processes stalled topoisomerase I-DNA complexesDefects cause spinocerebellar ataxia with axonal neuropathy

How Is base-excision repair, gap-filling Regulated?

Base-excision repair gap-filling is regulated at multiple levels. The expression and activity of POLB can be modulated by post-translational modifications, including phosphorylation and ubiquitination. APEX1 activity is regulated by redox status and protein-protein interactions. PARP1 activation at DNA damage sites promotes the recruitment of BER factors, including POLB and LIG3. Additionally, the choice between short-patch and long-patch BER is influenced by the type of lesion, cell cycle stage, and availability of repair proteins. Environmental toxicants can impair gap-filling and ligation, leading to repair deficiency.

base-excision repair, gap-filling and Human Disease

GeneDisease / BiologyPotential Experimental Model
POLBCancer, alkylating agent sensitivityPOLB knockout cell lines, point mutants
MUTYHMUTYH-associated polyposis (colorectal cancer)MUTYH knockout mice, organoids
TDP1Spinocerebellar ataxia with axonal neuropathyTDP1 knockout neurons, iPSC-derived models
XRCC1Cancer, neurological disordersXRCC1 mutant cell lines, knock-in mice
APEX1Cancer, neurodegenerationAPEX1 knockdown/knockout cells
Cancer and genomic instability
Defects in BER gap-filling can lead to accumulation of mutations and genomic instability, which are hallmarks of cancer. For example, mutations in POLB have been found in various cancers, and reduced POLB activity is associated with increased sensitivity to alkylating agents. MUTYH mutations cause MUTYH-associated polyposis, a hereditary colorectal cancer syndrome. Additionally, PARP inhibitors exploit defects in BER to induce synthetic lethality in BRCA-mutated cancers.
Neurodegeneration
Neurons are particularly vulnerable to DNA damage due to high metabolic activity and limited proliferative capacity. Defects in BER gap-filling have been implicated in neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis. For instance, mutations in TDP1 cause spinocerebellar ataxia with axonal neuropathy, and reduced BER capacity is observed in aging brains.
Epigenetic regulation and development
Active DNA demethylation involves BER gap-filling to replace oxidized 5-methylcytosine derivatives. This process is essential for cell fate specification and embryonic development. Disruption of gap-filling during demethylation can affect gene expression programs and lead to developmental abnormalities.

From base-excision repair, gap-filling-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the role of POLB in gap-filling?POLB knockout cell lines (e.g., HeLa, HEK293)
How do point mutations in POLB affect catalytic activity?POLB point-mutant knock-in cells
Does gap-filling contribute to active DNA demethylation?Knock-in of tagged POLB, APEX1; reporter assays
What is the impact of gap-filling defects on cancer therapy?Overexpression of POLB in cancer cell lines; xenograft models
How is gap-filling coordinated with ligation?Biochemical reconstitution with purified proteins
What is the evolutionary conservation of gap-filling?Mimiviral BER reconstitution

How to Study the base-excision repair, gap-filling Process

MethodWhat It MeasuresTypical Application
Biochemical reconstitutionGap-filling activity, dRP lyase activity, ligationMechanistic studies of POLB and APEX1
Comet assayDNA single-strand breaksAssessing BER capacity in cells
RNA-seqGene expression changesTranscriptional response to DNA damage
Whole-genome sequencingMutational signaturesIdentifying BER deficiency in tumors
CRISPR knockoutLoss-of-function phenotypesDetermining gene essentiality in BER
CRISPR knock-inTagged protein localizationStudying protein interactions in gap-filling
Cell extract assayBER activity in vitroMonitoring BER in model organisms
Mass spectrometryProtein-protein interactionsIdentifying BER complex components
Biochemical reconstitution assays
Biochemical reconstitution using purified BER proteins (e.g., POLB, APEX1, LIG3, XRCC1) allows detailed mechanistic studies of gap-filling. These assays can measure polymerase activity, dRP lyase activity, and ligation efficiency. They are also used to study channeling between enzymes.
Cell-based DNA repair assays
Cell extracts can be used to monitor BER gap-filling using defined DNA substrates containing AP sites or single-strand breaks. For example, Chlamydomonas reinhardtii cell extracts have been used to monitor BER. Comet assays and alkaline unwinding can measure overall BER capacity.
CRISPR-based knockout and knock-in models
CRISPR/Cas9 can generate knockout cell lines for POLB, APEX1, LIG3, and other BER genes to study their roles in gap-filling. Point mutations can be introduced to dissect catalytic domains. Knock-in of tagged proteins allows localization and interaction studies.
Next-generation sequencing and bioinformatics
RNA-seq can measure expression changes in BER genes upon DNA damage. Whole-genome sequencing can identify mutations arising from gap-filling defects. Bioinformatics tools can analyze mutational signatures associated with BER deficiency.

How CRISPR Can Be Used to Study GO:0006287 base-excision repair, gap-filling

Knockout

CRISPR knockout of POLB, APEX1, or LIG3 can reveal their essential roles in gap-filling. For example, POLB knockout cells are viable but sensitive to alkylating agents, indicating that backup polymerases can partially compensate. Knockout of APEX1 is embryonic lethal in mice, underscoring its critical function.

Point Mutation

Point mutations in the catalytic domains of POLB (e.g., D256A, E295K) can abolish gap-filling activity without affecting protein stability. These mutants are valuable for dissecting the enzymatic mechanism and for studying the consequences of specific repair defects.

Knock-in

Knock-in of tagged POLB (e.g., GFP or FLAG) allows live-cell imaging and immunoprecipitation to study its dynamics and interactions during gap-filling. Knock-in of disease-associated mutations can model human disorders.

Overexpression

Overexpression of POLB or other gap-filling enzymes can be used to study their effects on DNA repair capacity, mutagenesis, and drug sensitivity. For example, overexpression of POLB in cancer cells may increase resistance to alkylating agents.

How EDITGENE Supports base-excision repair, gap-filling Research

Researchers studying base-excision repair, gap-filling-related genes often need to determine whether a candidate gene is causally involved in the repair process, how specific mutations affect enzyme activity, and whether targeting these genes can sensitize cancer cells to therapy. EDITGENE provides comprehensive CRISPR-based services to address these questions.
Contact EDITGENE today to design your custom CRISPR model for base-excision repair, gap-filling research.

Frequently Asked Questions About base-excision repair, gap-filling

Base-excision repair gap-filling (GO:0006287) is the step in BER where an AP endonuclease removes a few bases and a DNA polymerase fills the gap using the undamaged strand as a template.
Key genes include POLB, APEX1, LIG3, XRCC1, and various DNA glycosylases [1,6].
DNA polymerase beta (POLB) is the primary gap-filling enzyme in short-patch BER.
Short-patch BER involves a single nucleotide gap filled by POLB, while long-patch BER involves 2-10 nucleotides and uses replicative polymerases.
Defects are linked to cancer, neurodegeneration, and developmental disorders.
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to study gap-filling genes.
POLB fills single-nucleotide gaps and removes 5'-dRP groups during short-patch BER.
It is regulated by protein-protein interactions, post-translational modifications, and cellular signaling.
Biochemical reconstitution, comet assays, and cell extract assays are commonly used [5,7].
Gap-filling is required for active DNA demethylation, which affects gene expression and cell fate.

Conclusion

Base-excision repair gap-filling (GO:0006287) is a fundamental biological process that ensures the completion of DNA repair after damaged base removal. Its mechanisms are highly conserved and involve a coordinated interplay between AP endonucleases, DNA polymerases, and ligases. Defects in gap-filling contribute to cancer, neurodegeneration, and developmental disorders, making it a critical area of research. Advances in CRISPR-based models and biochemical assays continue to unravel the complexities of this process, offering potential therapeutic targets for a range of diseases.

References

  1. 1. Beard WA et al.. 2019. DNA polymerase beta and other gap-filling enzymes in mammalian base excision repair.. Enzymes 45:1-26 PMID: 31627875
  2. 3. Wang D et al.. 2022. Active DNA demethylation promotes cell fate specification and the DNA damage response.. Science 378(6623):983-989 PMID: 36454826
  3. 4. Çağlayan M et al.. 2015. Reprint of "Oxidant and environmental toxicant-induced effects compromise DNA ligation during base excision DNA repair".. DNA Repair (Amst) 36:86-90 PMID: 26596511
  4. 5. Morales-Ruiz T et al.. 2018. Monitoring base excision repair in Chlamydomonas reinhardtii cell extracts.. DNA Repair (Amst) 65:34-41 PMID: 29547780
  5. 6. Kim YJ et al.. 2012. Overview of base excision repair biochemistry.. Curr Mol Pharmacol 5(1):3-13 PMID: 22122461
  6. 7. Çağlayan M. 2020. Pol β gap filling, DNA ligation and substrate-product channeling during base excision repair opposite oxidized 5-methylcytosine modifications.. DNA Repair (Amst) 95:102945 PMID: 32853828
  7. 8. Lad SB et al.. 2023. Biochemical Reconstitution of the Mimiviral Base Excision Repair Pathway.. J Mol Biol 435(17):168188 PMID: 37380013
Contact Us
*
*
*
*
How did you hear about us: